Flavonones from Ameliorate Hepatic Steatosis by Activating the SIRT1/AMPK Pathway in HepG2 Cells

about

Flavonones from Ameliorate Hepatic Steatosis by Activating the SIRT1/AMPK Pathway in HepG2 Cells

Item

http://www.wikidata.org/entity/Q58697142

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Flavonones from Ameliorate Hep ...... T1/AMPK Pathway in HepG2 Cells

@en

Flavonones from Ameliorate Hep ...... T1/AMPK Pathway in HepG2 Cells

@nl

type

Item

label

Flavonones from Ameliorate Hep ...... T1/AMPK Pathway in HepG2 Cells

@en

Flavonones from Ameliorate Hep ...... T1/AMPK Pathway in HepG2 Cells

@nl

prefLabel

Flavonones from Ameliorate Hep ...... T1/AMPK Pathway in HepG2 Cells

@en

Flavonones from Ameliorate Hep ...... T1/AMPK Pathway in HepG2 Cells

@nl

P1476

Flavonones from Ameliorate Hep ...... T1/AMPK Pathway in HepG2 Cells

@en

P2093

Nan Zhang

http://www.w3.org/2001/XMLSchema#string

Rong-Rong Xu

http://www.w3.org/2001/XMLSchema#string

Wei-Wei Guo

http://www.w3.org/2001/XMLSchema#string

Wen-Wen Zhao

http://www.w3.org/2001/XMLSchema#string

Xiao-Qing Chen

http://www.w3.org/2001/XMLSchema#string

Xing Wang

http://www.w3.org/2001/XMLSchema#string

Yin-Ying Ba

http://www.w3.org/2001/XMLSchema#string

P2860

Role of AMP-activated protein kinase in mechanism of metformin action

SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity

Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway

CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations

Human fatty acid synthase: role of interdomain in the formation of catalytically active synthase dimer

From NAFLD in clinical practice to answers from guidelines

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

P304

2555

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/IJMS19092555

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Xia Wu

P577

2018-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30154382

http://www.w3.org/2001/XMLSchema#string

P921

molecular biology

catalysis

P932

6165420

http://www.w3.org/2001/XMLSchema#string